RO7443904
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7443904, covering 2024-08-23 to 2024-08-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 1]